About：Policy & Evidence Standards
Peptides are a high-risk area of health information: marketing claims are dense, evidence quality varies widely, and regulatory categories overlap. This page explains how content on this site is produced, what standards it follows, and what we refuse to say — read it before any article.
What We Do and Don’t Do
Section titled “What We Do and Don’t Do”| We do | We don’t do |
|---|---|
| Explain mechanisms and pathways | Diagnose, prescribe, or give individualized medical advice |
| Label evidence levels honestly | Present in-vitro/animal studies as “proven” |
| Provide practical quality-control tools (reconstitution, COA, storage) | Sell products or publish buyer rankings |
| Compare ingredients and specifications | Pad pages with irrelevant citations |
Evidence Grading
Section titled “Evidence Grading”All research claims use one consistent scheme (each page’s “Evidence Note” follows it):
| Level | Meaning | How to read it |
|---|---|---|
| In-vitro / mechanistic | Cell and pathway level | Explains “how it might work” only |
| Animal study | Model-level effect | Directional reference; doses need conversion |
| Small human study | Preliminary signal | Check endpoints and controls |
| Randomized controlled trial (RCT) | Highest reliability | Check sample size, duration, funding |
| Review / systematic review | Evidence synthesis | Check inclusion criteria and heterogeneity |
“Studied” is not “settled”; “mechanism is clear” is not “the finished product works”.
Citation Policy
Section titled “Citation Policy”- Only real, verifiable references: PMIDs are given wherever possible so readers can verify on PubMed.
- Only references relevant to the page: no decorative reviews unrelated to the topic — irrelevant citations inflate perceived evidence.
- Limitations stated honestly: small samples, industry funding, lack of human controls are all disclosed.
- No fabrication: where no reliable source exists, we write “not established” rather than invent numbers.
Authorship and Review
Section titled “Authorship and Review”- Author: HSL Peptide Editorial — content is written by the editorial team, following the policy and evidence standards on this page.
- Scientific Advisor: Dr. Ana Laura M., PhD in Biological Sciences (reproductive medicine, fertility and molecular biology), Scientific & Medical Writer, verified Kolabtree profile. The advisor provides directional oversight on mechanisms and evidence grading; page-level reviews proceed in batches, and reviewed pages carry the reviewer’s name and review date in the footer.
- Found a factual error or a bad citation? Contact the editorial team; verified corrections are applied and noted at the end of the article.
Editorial Workflow
Section titled “Editorial Workflow”Topic Selection and Scoping
Section titled “Topic Selection and Scoping”Topics come from reader questions and scenario gaps: first locate the problem in the symptom guides, for example Skin Barrier, Collagen and Laxity, and Deep Sleep, then confirm whether an entry already covers it. On the ingredient side, start from Peptide Basics and Peptide Therapy Overview to avoid duplicate projects.
Drafting and Review
Section titled “Drafting and Review”Drafts follow a four-part structure — mechanism, evidence, practice, boundaries. Mechanistic terms are aligned with the Signaling and Skin Repair glossaries, and nutrient or excipient names with Nutrition and Amino Acids. Practical data defer to the four tool guides: Reconstitution, COA, Storage, and Bioavailability. After drafting we run a terminology-consistency pass, then re-check that evidence grading follows this page’s scheme.
Publishing and Updating
Section titled “Publishing and Updating”Before publishing we verify that internal links resolve and citations are checkable. New reviews or topics whose conclusions may reverse enter an update queue, with high-traffic pages handled first.
Correction Log
Section titled “Correction Log”Corrections are handled at three levels: factual errors (numbers, names, attribution of conclusions) are fixed immediately and noted at the end of the article; unclear wording is folded into the next content update; dead links are repaired in batches during internal-link checks. Corrections do not change how evidence levels are labeled; conclusions are tracked through end-of-article notes.
| Level | Trigger | Handling |
|---|---|---|
| Factual error | Wrong number, name, or attribution | Fixed immediately, noted at end of article |
| Unclear wording | Reader reports misunderstanding | Folded into the next content update |
| Dead link | Target page moved or removed | Repaired in batch with link checks |
Contact and Collaboration
Section titled “Contact and Collaboration”Reporting Errors
Section titled “Reporting Errors”Found a wrong number, name, or citation? Contact the editorial team through the channel given in the footer byline; verified issues are handled by correction level, consistent with the Citation Policy.
Medical Review Collaboration
Section titled “Medical Review Collaboration”A scientific advisor is now onboard (see “Authorship and Review” above), with page-level reviews proceeding in batches; we also welcome additional credentialed reviewers to help verify evidence grading and the boundaries of wording. Review improves wording quality only — it does not change this site’s stance of giving no clinical advice.
Licensing and Reposting
Section titled “Licensing and Reposting”Content on this site is educational. Reposts must keep the source, evidence grading, and disclaimer. Discussions of specific ingredients should be quoted with their surrounding context, for example the Fixed-Ratio Blends and Topical Signal Peptides entries.
Related Reading
Section titled “Related Reading”Further retrieval: Peptides and Formulation, Endocrine and Metabolic, Oral Collagen Peptides, Pigmentation, Tendon Injury.